227 related articles for article (PubMed ID: 20966070)
1. Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.
George J; Motshwene PG; Wang H; Kubarenko AV; Rautanen A; Mills TC; Hill AV; Gay NJ; Weber AN
J Biol Chem; 2011 Jan; 286(2):1341-53. PubMed ID: 20966070
[TBL] [Abstract][Full Text] [Related]
2. Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.
Yamamoto T; Tsutsumi N; Tochio H; Ohnishi H; Kubota K; Kato Z; Shirakawa M; Kondo N
Mol Immunol; 2014 Mar; 58(1):66-76. PubMed ID: 24316379
[TBL] [Abstract][Full Text] [Related]
3. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling.
Lin SC; Lo YC; Wu H
Nature; 2010 Jun; 465(7300):885-90. PubMed ID: 20485341
[TBL] [Abstract][Full Text] [Related]
4. Conformational Changes Induced by S34Y and R98C Variants in the Death Domain of Myd88.
Gosu V; Won K; Oh JD; Shin D
Front Mol Biosci; 2020; 7():27. PubMed ID: 32266286
[TBL] [Abstract][Full Text] [Related]
5. MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling.
Moncrieffe MC; Bollschweiler D; Li B; Penczek PA; Hopkins L; Bryant CE; Klenerman D; Gay NJ
Structure; 2020 Mar; 28(3):281-289.e3. PubMed ID: 31995744
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling.
De Nardo D; Balka KR; Cardona Gloria Y; Rao VR; Latz E; Masters SL
J Biol Chem; 2018 Sep; 293(39):15195-15207. PubMed ID: 30076215
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells.
Loiarro M; Volpe E; Ruggiero V; Gallo G; Furlan R; Maiorino C; Battistini L; Sette C
J Biol Chem; 2013 Oct; 288(42):30210-30222. PubMed ID: 24019529
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling.
De S; Karim F; Kiessu E; Cushing L; Lin LL; Ghandil P; Hoarau C; Casanova JL; Puel A; Rao VR
J Biol Chem; 2018 Sep; 293(39):15208-15220. PubMed ID: 30115681
[TBL] [Abstract][Full Text] [Related]
9. IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly.
Ferrao R; Zhou H; Shan Y; Liu Q; Li Q; Shaw DE; Li X; Wu H
Mol Cell; 2014 Sep; 55(6):891-903. PubMed ID: 25201411
[TBL] [Abstract][Full Text] [Related]
10. Oncogenically active MYD88 mutations in human lymphoma.
Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
[TBL] [Abstract][Full Text] [Related]
11. Small Molecule Mimetics of α-Helical Domain of IRAK2 Attenuate the Proinflammatory Effects of IL-33 in Asthma-like Mouse Models.
Li J; Saruta K; Dumouchel JP; Magat JM; Thomas JL; Ajami D; Rebek M; Rebek J; Bigby TD
J Immunol; 2018 Jun; 200(12):4036-4043. PubMed ID: 29728508
[TBL] [Abstract][Full Text] [Related]
12. Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases.
Loiarro M; Gallo G; Fantò N; De Santis R; Carminati P; Ruggiero V; Sette C
J Biol Chem; 2009 Oct; 284(41):28093-28103. PubMed ID: 19679662
[TBL] [Abstract][Full Text] [Related]
13. Clinical IRAK4 deficiency caused by homozygosity for the novel
Jia A; James E; Lu HY; Sharma M; Modi BP; Biggs CM; Hildebrand KJ; Chomyn A; Erdle S; Kular H; Turvey SE
Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32532880
[TBL] [Abstract][Full Text] [Related]
14. Examining Myddosome Formation by Luminescence-Based Mammalian Interactome Mapping (LUMIER).
Wolz OO; Koegl M; Weber ANR
Methods Mol Biol; 2018; 1714():119-130. PubMed ID: 29177859
[TBL] [Abstract][Full Text] [Related]
15. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human IRAK1.
Wang L; Qiao Q; Ferrao R; Shen C; Hatcher JM; Buhrlage SJ; Gray NS; Wu H
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13507-13512. PubMed ID: 29208712
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of MyD88S mediated signal termination.
Pustelny K; Kuska K; Gorecki A; Musielak B; Dobosz E; Wladyka B; Koziel J; Czarna A; Holak T; Dubin G
Cell Commun Signal; 2022 Jan; 20(1):10. PubMed ID: 35057808
[TBL] [Abstract][Full Text] [Related]
18. Natural loss-of-function mutation of myeloid differentiation protein 88 disrupts its ability to form Myddosomes.
Nagpal K; Plantinga TS; Sirois CM; Monks BG; Latz E; Netea MG; Golenbock DT
J Biol Chem; 2011 Apr; 286(13):11875-82. PubMed ID: 21325272
[TBL] [Abstract][Full Text] [Related]
19. MyD88 oligomer size functions as a physical threshold to trigger IL1R Myddosome signaling.
Deliz-Aguirre R; Cao F; Gerpott FHU; Auevechanichkul N; Chupanova M; Mun Y; Ziska E; Taylor MJ
J Cell Biol; 2021 Jul; 220(7):. PubMed ID: 33956941
[TBL] [Abstract][Full Text] [Related]
20. Data-Driven Modeling Identifies TIRAP-Independent MyD88 Activation Complex and Myddosome Assembly Strategy in LPS/TLR4 Signaling.
Li X; Zhong CQ; Yin Z; Qi H; Xu F; He Q; Shuai J
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
